Randall Lipps Net Worth

The estimated Net Worth of Randall A Lipps is at least $61.5 Milion dollars as of 8 June 2023. Mr. Lipps owns over 4,000 units of Omnicell stock worth over $13,729,338 and over the last 21 years he sold OMCL stock worth over $40,590,898. In addition, he makes $7,208,970 as Chairman of the Board, President oraz Chief Executive Officer at Omnicell.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Lipps OMCL stock SEC Form 4 insiders trading

Randall has made over 152 trades of the Omnicell stock since 2003, according to the Form 4 filled with the SEC. Most recently he bought 4,000 units of OMCL stock worth $295,040 on 8 June 2023.

The largest trade he's ever made was exercising 124,910 units of Omnicell stock on 18 March 2014 worth over $2,044,777. On average, Randall trades about 12,899 units every 35 days since 2003. As of 8 June 2023 he still owns at least 318,768 units of Omnicell stock.

You can see the complete history of Mr. Lipps stock trades at the bottom of the page.

Randall Lipps biography

Randall A. Lipps is Chairman of the Board, President, Chief Executive Officer of Omnicell Inc. He has served as Chairman of the Board and a director of Omnicell since founding Omnicell in September 1992 and as its President and Chief Executive Officer since October 2002. From June 2013 to October 2018, Mr. Lipps was a director of Invuity, Inc., a medical device company. Mr. Lipps serves as a member of the Board of Trustees of the American Nurses Foundation. Mr. Lipps received both a B.S. in economics and a B.B.A. from Southern Methodist University. The Corporate Governance Committee believes Mr. Lipps' extensive knowledge of the Company, including his founding of the Company and his nearly three decades of leading the Company as the President and CEO, provide the Board with invaluable current knowledge of the Company and extensive knowledge of the industry's needs for improvements in healthcare economics and patient safety. In addition, his role in the operations of the Company provides the Board with the practical understanding of the issues and opportunities that face the Company.

What is the salary of Randall Lipps?

As the Chairman of the Board, President oraz Chief Executive Officer of Omnicell, the total compensation of Randall Lipps at Omnicell is $7,208,970. There are no executives at Omnicell getting paid more.

How old is Randall Lipps?

Randall Lipps is 62, he's been the Chairman of the Board, President oraz Chief Executive Officer of Omnicell since 2002. There are 7 older and 11 younger executives at Omnicell. The oldest executive at Omnicell, Inc. is Sara White, 74, who is the Independent Director.

What's Randall Lipps's mailing address?

Randall's mailing address filed with the SEC is OMNICELL, INC., 4220 NORTH FREEWAY, FORT WORTH, TX, 76137.

Insiders trading at Omnicell

Over the last 22 years, insiders at Omnicell have traded over $118,258,750 worth of Omnicell stock and bought 526,030 units worth $5,215,749 . The most active insiders traders include William H Jr Younger, Randall A Lipps oraz Benjamin A Horowitz. On average, Omnicell executives and independent directors trade stock every 10 days with the average trade being worth of $482,255. The most recent stock trade was executed by Christine Marie Mellon on 9 June 2023, trading 7,951 units of OMCL stock currently worth $581,536.

What does Omnicell do?

since 1992, omnicell has been creating new efficiencies to improve patient care, anywhere it is delivered. omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. omnicell’s automated hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. our supply management systems promote greater cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. omnicell® products range from high-security, closed-cabinet systems and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room. more than 3,200 customers worldwide have utilized omnice

Complete history of Mr. Lipps stock trades at Omnicell

Omnicell executives and stock owners

Omnicell executives and other stock owners filed with the SEC include:

• Randall Lipps,
  Chairman of the Board, President, Chief Executive Officer
• Peter Kuipers,
  Chief Financial Officer, Executive Vice President
• Scott Seidelmann,
  Executive Vice President and Chief Commercial Officer
• Randall A. Lipps,
  Founder, Exec. Chairman, Pres & CEO
• Nhat Ngo,
  Executive Vice President - Marketing, Strategy and Business Development
• Daniel Johnston,
  Executive Vice President, Chief Legal and Administrative Officer
• Peter J. Kuipers,
  Exec. VP & CFO
• Scott Peter Seidelmann,
  Exec. VP & Chief Commercial Officer
• Christine Mellon,
  Exec. VP, Chief Admin. & People Officer
• Robin Seim,
  Director
• Bruce Scott,
  Independent Director
• James Judson,
  Lead Independent Director
• Joanne Bauer,
  Independent Director
• Mark Parrish,
  Independent Director
• Sara White,
  Independent Director
• Vance Moore,
  Independent Director
• Bruce Smith,
  Independent Director
• Joseph Spears,
  Senior Vice President, Chief Accounting Officer, Corporate Controller
• Jorge R. Taborga,
  Exec. VP of Engineering & Integration Management Officer
• Roxanne Turner,
  VP of Corp. Responsibility & Chief Compliance Officer
• Corey J. Manley,
  Sr. VP & Chief Legal Officer
• Kathleen Nemeth,
  Sr. VP of Investor Relations
• Giri Chodavarapu,
  Sr. VP & Chief Information Officer
• Joseph Brian Spears,
  Sr. VP, Chief Accounting Officer & Corp. Controller
• Gary S Petersmeyer,
  Director
• Jorge R. Taborga,
  Executive VP. Engineering
• J Christopher Drew,
  EVP, Business Development
• Randy D Lindholm,
  Director
• Corey J Manley,
  EVP&CHIEF LEGAL/ADMIN OFFICER
• Nchacha Etta,
  EVP & CFO
• Kaushik Ghoshal,
  
• Marga Ortigas Wedekind,
  Vice President, Marketing
• Donald C Wegmiller,
  Director
• Mary E Foley,
  Director
• William G. Shields,
  Executive Vice President
• Michael D Stevenson,
  Exec. VP, Global Manufacturing
• Joseph E Whitters,
  Director
• William H Jr Younger,
  Director
• Partners Iii Llc Abs,
  10% owner
• Renee M Luhr,
  VP Sales
• Brock Nelson,
  Director
• Brian Robert Rodli,
  Vice President/Marketing
• Charles J Barnett,
  Director
• Benjamin A Horowitz,
  Director
• Timothy T Weglicki,
  10% owner
• John D Jr Stobo,
  Director
• Capital Partners Iii L P Abs,
  10% owner
• John D Higham,
  SVP Marketing
• Kevin L Roberg,
  Director
• John Choma,
  S.V.P. H.R. Emp. Learn & Perf.
• Dennis P Wolf,
  Exec VP, CFO
• Gary E Wright,
  Exec VP Sales
• Donald B Jr Hebb,
  10% owner
• Chusak Siripocanont,
  Sr. VP, Eng., Mfg. & Quality
• Edward Peter Bousa,
  
• Eileen J. Voynick,
  
• Mary Garrett,
  
• Dan S Johnston,
  EVP, EXECUTIVE ADVISOR
• Christine Marie Mellon,
  EVP, EXECUTIVE ADVISOR
• Brian H. Nutt,
  VP, Chief Accounting Officer